Objective : This study investigated the clinical and angiographic outcomes of treatment with stent-assisted coil embolization using the Solitaire AB stents for wide-necked intracranial aneurysms.
INTRODUCTION
The use of self-expanding stents has revolutionized endovascular treatment (EVT) of wide-necked aneurysms. 11) These stents provide support to minimize the risk of coil herniation into the parent vessel, potentially provide a scaffold for orifice endothelialization and permit increased packing density of the aneurysm. 16 ) 18) They also create flow diversion. 11) Self-expandable stents, such as the Neuroform and Enterprise, 1)14) are widely used in the treatment of wide necked aneurysms. Initial angiographic results
indicate that the use of the Neuroform stents result in complete occlusion rates of 17-94.4% and Enterprise stents 6.9%. 5)11) Navigation or deployment inability rates of 4-14% have been oserved with the use of the Neuroform stent, and distal migration rates of 1.4%
with the Enterprise stent. 7)10)11)15) The Solitaire AB stent (ev3, Irvine, CA, USA) was recently approved to treat intracranial aneurysms for these purposes.
The Solitaire AB stent is circular and cylindrical and is connected to a push-wire that is electrically detached after full deployment, allowing retrieval or repositioning of stent, superior to other stents. 8) This study retrospectively investigated the clinical and angiographic results of patients treated with stent-assisted coil embolization using Solitaire AB stent for wide-necked intracranial aneurysms.
MATERIALS AND METHODS

Patient populations
From Wide-necked aneurysms were defined by a neck width of ≥ 4 mm or a dome-to-neck ratio of < 2. 
Endovascular procedures
RESULTS
We performed the stent-assisted coil embolization us- Follow-up angiography was not performed on 3 patients who were lost to follow up.
Immediate post-embolization angiographic results
were classified as Class I in 12 patients (57.1%), Class Width: the short axis dome measurement of a cylindrical aneurysm, the dome/neck ratio is based on the height/neck ratio, Class I: no filling of the aneurysm neck or dome, Class II: residual filling of the neck but not the dome, Class III: residual filling of the neck and dome. D= dome; N= neck; F/U= follow-up; ICA= internal carotid artery; mRS= modified Rankin Scale; VA= vertebral artery; Lt= left; Rt= right. showed recanalization of the aneurysm neck on follow-up angiography. No stent migration or in-stent stenosis was seen on follow-up angiography.
With respect to clinical outcomes, fortunately, all of the patients achieved a mRS score of 0 during the follow-up period. The data and outcomes of all 21 patients are summarized in Table 1 . deployment failure rates of 4.1% for the Solitaire stent. In our case, despite very tortuous vessels, we did not find difficulty and failure in navigation and stent deployment (Fig. 1) .
A high degree of navigability is associated with excellent flexibility and an easy delivery system through Rapid Transit or Rebar 0.018 or 0.027 inch microcatheters. 8) We had experience repositioning Solitaire AB stents, which are fully retrievable and detachable. In our case, the stent was deployed and coil insertion was performed. However, we detected that 1 stent marker was outside the vessel. We thought that the stent marker might be in the small perforator. Therefore, we pulled the stent pusher wire out slightly. Finally, the stent was repositioned and the marker was inside the vessel (Fig. 2) . During the packing of coiling within the aneurysm with jailing technique, if microcatheter kick back occurs into the parent artery, a Solitaire AB stent can be recaptured within another microcatheter. After the selection of aneurysm, Solitaire stent can be re-deployed. In the case of branch vessel occlusion observed on angiography during the procedure, the stent is also retrieved and repositioned.
Like another self-expandable stents such as Neuroform Further analysis with long term follow-up is needed to support these observations.
In this study, no in-stent stenosis was observed during the follow-up period. Fiorella et al. 4) saw rates of 5.8% for in-stent stenosis using the Neuroform stent.
The Enterprise stent had in-stent stenosis rates of 8.6-25% in the treatment of aneurysms. 12) In addition, no stent migration was observed, possibly because of the stronger radial force of the Solitaire stent (0.0106 N/mm of stent length) compared to other stents. 8) Reported recanalization rate of aneurysms treated with Solitaire stents is 6.5%. 19) The Neuroform stent had recanalization rates of 1.3-5.8% and those of the Enterprise stent were 8.7-28.6%. 7)11)14) In this study, except for 3 patients who were lost to follow-up, 1 of 18 (5.6%) aneurysms recanalized, confirming total occlusion (Class I) on immediate postoperative angiography.
This study has some limitations. We did not have a control group, so we compared the results and outcome of this study to those of previously published studies. In addition, data were collected retrospectively and the number of patients was limited. The follow-up periods may not be long enough to result in any definitive conclusion. Therefore, longer follow-up and more clinical and angiographic data are needed to determine the efficacy and safety of Solitaire stent-assisted coil embolization in wide-necked aneurysm cases.
CONCLUSION
We carefully suggest that the Solitaire stent is associated with a high rate of technical success, good navigability, and increase the aneurysm occlusion rates on follow-up angiography. Long-term follow-up examination is mandatory to support these early observations.
